Table 2 Newcastle-Ottawa scoring of studies assessing efficacy
Study | Representativeness of the exposed cohort | Selection of the non-exposed cohort | Ascertainment of exposure | Outcome of intferest was not present at start | Comparability (score 0,1 or 2) | Assessment of outcome | Sufficient follow-up of outcome | Adequacy of follow up of cohorts | Score |
|---|---|---|---|---|---|---|---|---|---|
Thakuria, L., et al. | NA | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 7/9 |
Vanstraelen, K., et al. | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 7/9 |
Park, W. B., et al. | 1 | 1 | 1 | 1 | 1 | 1 | NA | 0 | 6/9 |
Cornely, O. A., et al. | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 9/9 |
Hummert, S. E., et al. | NA | 1 | 0 | 1 | 1 | 0 | 1 | 1 | 5/9 |
Chae, H., et al. | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 8/9 |
Maertens, J., et al. | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 8/9 |
Duarte, R. F., et al. | 1 | 1 | 1 | 1 | 1 | NA | 1 | 1 | 7/9 |
Desplanques, P. Y., et al. | NA | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 7/9 |
Bourdelin, M., et al. | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 8/9 |
Gross, B. N., et al. | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 8/9 |
Cattaneo, C., et al. | NA | 1 | 0 | 1 | 1 | NA | 1 | 1 | 5/9 |
Tonini, J., et al. | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 8/9 |
Ross, A. L., et al. | NA | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 7/9 |
Pavan, L., et al. | NA | 1 | 1 | 1 | 1 | NA | 1 | 1 | 6/9 |
Hoenigl, M., et al. | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 8/9 |
Eiden, C., et al. | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 7/9 |
Shields, R. K., et al. | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 8/9 |
Fanci, R., et al. | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 7/9 |
Bryant, A. M., et al. | NA | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 7/9 |
Welzen, M. E., et al. | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 7/9 |
Lebeaux, D., et al. | NA | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 7/9 |
Sengar | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 7/9 |
Döring | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 8/9 |
Liebenstein | 1 | 1 | NA | 1 | 2 | 1 | NA | 1 | 7/9 |
Tverdek | 1 | 1 | NA | 1 | 1 | 1 | NA | 1 | 6/9 |